Ignite Creation Date:
2024-05-05 @ 11:25 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01324232
Status:
COMPLETED
Last Update Posted:
2021-11-22
First Post:
2011-03-23
Brief Title:
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Sponsor:
Avanir Pharmaceuticals
Organization:
Avanir Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Sclerosis |
| Central Neuropathic Pain |
Keywords: